Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial

Hutchings, Martin ; Morschhauser, Franck ; Iacoboni, Gloria ; Carlo-Stella, Carmelo ; Offner, Fritz C ; Sureda, Anna ; Salles, Gilles ; Martínez-Lopez, Joaquín ; Crump, Michael ; Thomas, Denise N ; Morcos, Peter N ; Ferlini, Cristiano ; Bröske, Ann-Marie E ; Belousov, Anton ; Bacac, Marina ; Dimier, Natalie ; Carlile, David J ; Lundberg, Linda ; Perez-Callejo, David ; Umaña, Pablo ; Moore, Tom ; Weisser, Martin ; Dickinson, Michael J

Journal of clinical oncology, 2021-06, Vol.39 (18), p.JCO2003175-1970 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível